REVPEM
Live / Registered — Registered (as of 25 Aug 2020)
What this means for you
Registered since 25 Aug 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79278880
- Registration number
- 6132812
- Mark type
- Stylized text
- Filed
- 30 Nov 2019
- Published for opposition
- 09 Jun 2020
- Registered
- 25 Aug 2020
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; stem cells for pharmaceutical and medical purposes
- Class 044 — Medical, beauty and agricultural services: Collection and preservation of blood; collection and preservation services for tissue and cells, namely, collection and banking of umbilical cord tissue perivascular stem cells; medical diagnostic services
Owner
- NOVARTIS AG, CH
- NOVARTIS AG, CH
- NOVARTIS AG, CH
Prosecution history
- 25 Aug 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 03 Jan 2021 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 15 Dec 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 15 Dec 2020 — FINAL DISPOSITION PROCESSED
- 25 Nov 2020 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 25 Aug 2020 — REGISTERED-PRINCIPAL REGISTER
- 09 Jun 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jun 2020 — PUBLISHED FOR OPPOSITION
- 20 May 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Apr 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Apr 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Apr 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Apr 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 Apr 2020 — REFUSAL PROCESSED BY IB
- 18 Mar 2020 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB